In another sign of growing
pharmaceutical industry interest in targeted protein degradation, Celgene will pay Vividion Therapeutics $ 101 million in a four - year pact to develop small - molecule drugs for cancer, inflammation, and neurodegenerative diseases.
Macrocyclic peptides have sparked
pharmaceutical industry interest, because they have certain physical and chemical properties that could become the basis of a new generation of medications.
Not exact matches
Several Democratic senators pressed billionaire investor Carl Icahn on Monday to clarify his role as an adviser to President Donald Trump, saying his position in the administration raised «alarming» questions about potential conflicts of
interest with his stakes in the biofuels and
pharmaceutical industries.
Valeant's apparent lack of
interest in R&D has drawn concern from some analysts and
industry observers, who say research and development is the most important expenditure for
pharmaceutical companies.
«What will be
interesting to see is if we end up in a bidding war,» Waterhouse said, suggesting Teva Pharmaceutical
Industries and Valeant
Pharmaceuticals International as potential rival bidders.
The takeover
interest in Tesaro underscores the
pharmaceutical industry's strong appetite for the acquisition of biotechnology companies with promising medicines under development in lucrative sectors such as cancer treatment.
At the time, several Democratic lawmakers were pressing Icahn for details about his advisory role, saying his personal stakes in biofuels and
pharmaceutical industries posed potential conflicts of
interest.
But initially at least Canada was seen as an additional complication to completion of the TPP, a «difficult» negotiating partner that brought its own baggage (such as a less than robust IPR regime, a traditional antipathy to the
interests of the brand - name
pharmaceutical manufacturers, a penchant for protecting so - called «cultural
industries», and other trade issues that did not align with US
interests) that might have resonated with some of the other TPP countries.
Google Payday Loans algorithm update targeted spammy queries mostly associated with shady
industries (including super high
interest loans and payday loans, porn, casinos, debt consolidation, and
pharmaceuticals).
With the development of smarter packaging, this specialist for secondary packaging in the pharma /
pharmaceutical and healthcare
industry meets the needs of increased digitalisation on the e-health market and the growing
interest in interactive packaging solutions.
The company's flexibles packaging business — which services the
pharmaceutical, healthcare, food, beverage and tobacco
industries — produced an 8.5 per cent rise in profit before
interest and tax.
Would you be
interested in database of Gynaecology and Gynaecologists titles from Hospital & Health Care, medical Practice, Medical Devices,
Pharmaceuticals, Health, Wellness and Fitness
Industry?
I am not inclined to vote for you if you pander to the far right and the large corporate
interests in the insurance and
pharmaceutical industries during your campaign.
The list of top donors to housekeeping accounts is dominated by special
interests that are highly regulated and / or subsidized by state government: real estate firms, health - care and
pharmaceutical interests, labor unions, telecom companies, the beverage
industry, big tobacco and gambling
interests.
A Career in Drug Discovery and Development Wolfgang Sadée, professor of pharmacology at Ohio State University, offers an overview of drug discovery in the
pharmaceutical industry and outlines the range of opportunities available to students who are
interested in moving into this dynamic field.
Please do not misunderstand me: The
pharmaceutical industry is
interesting and challenging.
The untold millions of mice, rats, and even dogs owned by
pharmaceutical companies, biotech corporations, and other
industry labs are off the table says Bellotti, noting the business
interests of his more conservative allies.
Motivated by the
interests of a
pharmaceutical industry unlikely to profit from the treatments, Audley says, the society wants to «change the laws in all civilized countries to outlaw these therapies».
The profile on law, for example, fails to link to the pages of the Law Society (www.lawsociety.org.uk in case you are
interested) and the
pharmaceutical profile only links to the Association for the British
Pharmaceutical Industry.
«
Interest from the
pharmaceutical industry in Crispr - Cas9 gene editing has really taken off in the last year,» says Bill Lundberg, chief scientific officer at Crispr Therapeutics.
I knew that a postdoc wasn't necessarily going to set me out on that path, so I started talking to people in the
pharmaceutical industry who had
interesting jobs,» said Jim.
Lastly, even the
pharmaceutical and food
industry are showing
interest in tannins because tannins have antioxidant and antibacterial properties.
«The
pharmaceutical industry is showing great
interest.
So, according to plan, I spent 10 years in research in the
pharmaceutical industry (first with Wellcome and then Glaxo Wellcome), but as my career progressed I found myself becoming more and more
interested in the strategic challenges facing the
industry.
The Association of the German
Pharmaceutical Industry represents approximately 310 German
pharmaceutical companies and their
interests with respect to issues such as drug licensing and reimbursement policy.
The growing restrictions drove the older
industries in the chemical, petroleum and
pharmaceutical fields to protect their business
interests by opposing new regulations.
The
pharmaceutical industry is also
interested in gaining a better understanding of the endocannabinoid system so that it can better use specific components for
pharmaceutical purposes.
Meanwhile the biomedical
industry became
interested in the crab's blood because it can be used to test the sterility of medical and
pharmaceutical products.
Start - ups will especially benefit from the increased outsourcing strategies of the huge
pharmaceutical and chemical
industry, explains Bert Steffan, co-founder of the newly founded Thetys Corp. «Marine biotech is rapidly growing and opens highly
interesting possibilities for young researchers,» says Steffan.
The laboratory's Microscopy Core Facility Manager, Dr Raymond Wightman, said vaterite was of
interest to the
pharmaceutical industry: «Biochemists are working to synthetically manufacture vaterite as it has potential for use in drug delivery, but it is not easy to make.
«This is crucial in investigating covalent inhibitors, which react with their biological targets, and are the focus of growing
interest in the
pharmaceutical industry.»
Because my research
interests had always been clinically oriented, I was keen to explore the possibility of working as a clinical research associate (CRA) for the
pharmaceutical industry.
The main event is an annual meeting, bringing together companies and academics with an
interest in skin research but the Skin Forum also makes sure that it keeps abreast of current thinking and that research is aimed at something applicable and useful: «We commissioned a survey that was sent out to both
pharmaceutical and cosmetic
industries to see what areas of skin research were thought to be most relevant and should be covered in grant applications,» says Professor Hadgraft.
... We believe this decision is in the best
interests of the agriculture, biotechnology and
pharmaceutical industries.»
He says they actually have deep concerns about the
pharmaceutical industry, the insurance structure, and government regulations that they believe do not have their children's
interests at heart.
In writing this article about myself, I was able to look back over a very
interesting and fulfilling career in the
pharmaceutical industry, and it has made me realize that if I had to do it all again, I wouldn't change a thing.
These promising results have already raised the
interest of the
pharmaceutical industry and led the researchers to patent DGKi as a drug target, as they are keen to explore the issue further, searching for molecules that strongly inhibit DGKi without causing side - effects.
But with the exception of AIDS, the
pharmaceutical industry hasn't taken much
interest in developing vaccines for common diseases, because they don't expect to make a profit.
With political
interest peaking, «now is your chance, folks,» said NIAID director Anthony Fauci to the gathered researchers, public health experts, and executives from the
pharmaceutical and biotech
industry.
The chemical reactions she has developed are widely used throughout the
pharmaceutical industry to create new drug candidates, are being studied by chemical companies
interested in accessing important chemicals used in farming, and are being utilized to prepare a type of chemical (tracer) that allows doctors to view the heart's sympathetic nervous system through positron emission tomography (PET) scans.
She works with leaders in the healthcare and
pharmaceutical industry, NGOs, patient advocacy, and medical associations to align
interests and create high impact collaborations supporting the Angiogenesis Foundation's mission.
However, with few exceptions, the stem cell and regenerative medicine
industry has remained inadequately capitalized to carry out large - scale clinical trials independently, and major
pharmaceutical firms have tended to show more
interest in the use of hiPSCs as a source of large, pure populations of specific somatic cells for use in drug compound screening and toxicology tests, than they have in therapeutic uses of stem cells and their derivatives.
PV cells are therefore a very
interesting target for the
pharmaceutical industry.»
Problems are primarily motivated by health care technologies of
interest to
pharmaceutical and biotechnological companies, and emphasize multi-disciplinary collaborative interactions, including colleagues in both academia and
industry.
The
pharmaceutical industry is really getting
interested and supporting more interactions between basic laboratories and their own work.
The
pharmaceutical industry, and medicine in general, have a vested
interest in keep the population fat and sick, popping ever more pills and deteriorating anyway.
MK - 2866 was created and researched by
pharmaceutical industry due to increasing medical
interest in SARMs.
Of course, funding clinical trials is often cost - prohibitive and
pharmaceutical industry investors, with legally - binding fiduciary obligations to shareholder
interests, have little fiscal incentive to devote resources to dietary protocols for which market exclusivity is an impossibility.
Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors, including
interest rate and currency exchange rate fluctuations; the impact of
pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; Merck's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Merck's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.
Risks and uncertainties include but are not limited to, general
industry conditions and competition; general economic factors, including
interest rate and currency exchange rate fluctuations; the impact of
pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.